Meningococcal Group C Oligosaccharide

Records for this ingredient, by country (identity only).

ATC J07AH · 2 markets · 6 records

Meningococcal Group C Oligosaccharide 2 markets · 6 records Forms
Filters
MarketCA 2SG 1
Kind

CA 2 records · 2 shown of 2 Source Health Canada Drug Product Databas · Data as of 2026-10-23

Combination products containing this ingredient

  • 0.005 mg per mL / per unit basis not statedliquid CombinationMeningococcal Group A Oligosaccharide 0.01 mg + Meningococcal Group C Oligosaccharide 0.005 mg + Meningococcal Group W-135 Oligosaccharide 0.005 mg + Meningococcal Group Y Oligosaccharide 0.005 mgMENVEO
  • 0.005 mgpowder CombinationCorynebacterium Diphtheriae Crm-197 Protein 0.047 mg + Meningococcal Group A Oligosaccharide 0.01 mg + Meningococcal Group C Oligosaccharide 0.005 mg + Meningococcal Group W-135 Oligosaccharide 0.005 mg + Meningococcal Group Y Oligosaccharide 0.005 mgMENVEO

SG 1 records · 0 shown of 0 Source Health Sciences Authority (HSA) · Data as of 2026-08-07 · some records have no stated strength

1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商
With a brand name Con nombre comercial 有商品名 有商品名Menveo Powder and Solution for Solution for Injection ×1

Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包

Some strengths are recorded without a per mL / per unit basis. They are shown as recorded and are not compared with other markets.

The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.

A side-by-side table is offered only when this ingredient has records in many markets; otherwise this list is the whole picture.